Όλο το DSpace

Εμφάνιση απλής εγγραφής

Current and future aspects of TIM-3 as biomarker or as potential targeted in non-small cell lung cancer scope: Is there a role in clinical practice?

dc.creatorde Mello R.A., Zhu J.-H., Iavelberg J., Potim A.H., Simonetti D., Júnior J.A.S., Castelo-Branco P., Pozza D.H., Tajima C.C., Tolia M., Antoniou G.en
dc.date.accessioned2023-01-31T07:52:07Z
dc.date.available2023-01-31T07:52:07Z
dc.date.issued2020
dc.identifier10.21037/tlcr-20-625
dc.identifier.issn22186751
dc.identifier.urihttp://hdl.handle.net/11615/73142
dc.description.abstract[No abstract available]en
dc.language.isoenen
dc.sourceTranslational Lung Cancer Researchen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85100165611&doi=10.21037%2ftlcr-20-625&partnerID=40&md5=05e035fc1dda98c08a7515e923c669dc
dc.subjectafatiniben
dc.subjectalectiniben
dc.subjectanaplastic lymphoma kinaseen
dc.subjectatezolizumaben
dc.subjectbrigatiniben
dc.subjectcarboplatinen
dc.subjectCD4 antigenen
dc.subjectceritiniben
dc.subjectcrizotiniben
dc.subjectcytotoxic T lymphocyte antigen 4en
dc.subjectdacomitiniben
dc.subjectdurvalumaben
dc.subjecterlotiniben
dc.subjectgamma interferonen
dc.subjectgefitiniben
dc.subjecthepatitis A virus cellular receptor 1en
dc.subjecthepatitis A virus cellular receptor 2en
dc.subjectipilimumaben
dc.subjectKi 67 antigenen
dc.subjectlag3 proteinen
dc.subjectlorlatiniben
dc.subjectnivolumaben
dc.subjectosimertiniben
dc.subjectox40 proteinen
dc.subjectpaclitaxelen
dc.subjectpembrolizumaben
dc.subjectpemetrexeden
dc.subjectplaceboen
dc.subjectprogrammed death 1 ligand 1en
dc.subjecttim 4 proteinen
dc.subjecttranscription factor FOXP3en
dc.subjecttumor necrosis factor receptor superfamily member 9en
dc.subjectunclassified drugen
dc.subjectallergic diseaseen
dc.subjectblooden
dc.subjectcancer chemotherapyen
dc.subjectcancer immunotherapyen
dc.subjectcancer radiotherapyen
dc.subjectcancer stagingen
dc.subjectcancer surgeryen
dc.subjectcancer survivalen
dc.subjectCD8+ T lymphocyteen
dc.subjectcellular immunityen
dc.subjectclinical practiceen
dc.subjectclinical trial (topic)en
dc.subjectcost effectiveness analysisen
dc.subjectdendritic cellen
dc.subjectdrug targetingen
dc.subjectflow cytometryen
dc.subjectFriend murine leukemia virusen
dc.subjectgene mutationen
dc.subjecthepatitis Ben
dc.subjectHepatitis B virusen
dc.subjecthepatitis Cen
dc.subjectHepatitis C virusen
dc.subjecthumanen
dc.subjectHuman immunodeficiency virus infectionen
dc.subjectlung canceren
dc.subjectLymphocytic choriomeningitis virusen
dc.subjectmacrophageen
dc.subjectmalignant neoplasmen
dc.subjectmelanomaen
dc.subjectmolecular biologyen
dc.subjectnon small cell lung canceren
dc.subjectoverall survivalen
dc.subjectperipheral blood mononuclear cellen
dc.subjectprogression free survivalen
dc.subjectprotein expressionen
dc.subjectprotein functionen
dc.subjectrandomized controlled trial (topic)en
dc.subjectregulatory mechanismen
dc.subjectregulatory T lymphocyteen
dc.subjectReviewen
dc.subjectstomach canceren
dc.subjectsynergistic effecten
dc.subjectsystemic therapyen
dc.subjectT lymphocyteen
dc.subjectT lymphocyte subpopulationen
dc.subjectTh1 cellen
dc.subjecttumor growthen
dc.subjecttumor immunityen
dc.subjecttumor immunogenicityen
dc.subjecttumor modelen
dc.subjectAME Publishing Companyen
dc.titleCurrent and future aspects of TIM-3 as biomarker or as potential targeted in non-small cell lung cancer scope: Is there a role in clinical practice?en
dc.typeotheren


Αρχεία σε αυτό το τεκμήριο

ΑρχείαΜέγεθοςΤύποςΠροβολή

Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στις ακόλουθες συλλογές

Εμφάνιση απλής εγγραφής